How Wegovy And Mounjaro Dosing Protocols Actually Compare
Genuine Novo Nordisk Wegovy: Why Authenticity Matters In Dose Comparisons
When comparing Wegovy and Mounjaro dose schedules, medication authenticity becomes paramount for accurate treatment outcomes. Counterfeit semaglutide products have infiltrated UK markets with incorrect dosing, expired ingredients, or dangerous substitutes that render any dose comparison meaningless. EverydayMeds sources 100% genuine Novo Nordisk Wegovy directly from licensed UK wholesalers, ensuring every pen contains precisely the stated semaglutide concentration for reliable dose escalation. Each authentic Wegovy pen features distinctive FlexTouch branding, traceable batch numbers, and MHRA-authorised packaging that counterfeit versions cannot replicate.
Our GPhC-registered pharmacy (#9012878) maintains full supply chain documentation, allowing patients to verify their medication's journey from Novo Nordisk manufacturing through to delivery. This traceability becomes crucial when following Wegovy's structured 20-week escalation protocol, where each dose build upon the previous stage's tolerance. Authentic Wegovy ensures predictable pharmacokinetics at each escalation stage, whilst counterfeit products may cause unpredictable responses that compromise both safety and efficacy throughout the dosing comparison journey.
Wegovy Vs Mounjaro Dose Comparison: Complete Pricing Structure
Wegovy follows a 5-stage dose escalation over 20 weeks, starting with 0.25mg (£79.99) for weeks 1-4, progressing through 0.5mg (£94.99) for weeks 5-8, 1mg (£99.99) for weeks 9-12, 1.7mg (£139.99) for weeks 13-16, reaching maintenance 2.4mg (£209.99) from week 17 onwards. Mounjaro uses a 4-stage protocol with different timeframes and pricing. New customers apply discount code FIRST40 at checkout, whilst returning patients use DOSE25 to reach these final prices. Our Intro Trio bundle provides Wegovy's first three doses (0.25mg, 0.5mg, 1mg) for £299.99, covering 12 weeks of initial escalation in one convenient order.
The dose comparison reveals Wegovy's more gradual escalation approach, spending 4 weeks at each strength compared to Mounjaro's variable timing. This extended escalation may reduce side effects for some patients, though individual tolerance varies. Our Gentle Start Trio (0.25mg, 0.25mg, 0.5mg) for £269.99 allows extended time at the lowest dose for particularly sensitive patients. Both medications require prescription-only access through clinical assessment, but Wegovy's established 5-stage protocol offers predictable progression planning for long-term weight management budgeting.
Clinical Evidence Supporting Wegovy And Mounjaro Dose Escalation Protocols
The STEP clinical trial programme established Wegovy's dose escalation schedule through systematic testing in over 4,500 patients. STEP 1 demonstrated that patients following the complete 5-stage escalation alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The structured dose comparison showed optimal tolerance when patients spent full 4-week periods at each strength before advancing. STEP 5 confirmed sustained efficacy with approximately clinically studied weight loss maintained at 2 years when patients adhered to the prescribed escalation protocol.
Mounjaro's SURMOUNT trials used different escalation timing and dual GIP/GLP-1 mechanism, making direct weight loss percentage comparisons inappropriate due to varying trial designs and populations. Both medications demonstrated efficacy in their respective clinical programmes, but the dose comparison reveals different approaches to minimising gastrointestinal side effects during escalation. Individual response varies significantly, and your prescriber can help determine which escalation protocol may suit your tolerance profile and treatment goals.
How Wegovy Works: GLP-1 Mechanism In Dose Comparison Context
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural incretin hormones regulating appetite and satiety. As doses escalate from 0.25mg to 2.4mg maintenance, increased semaglutide concentrations progressively enhance appetite suppression and promote earlier feelings of fullness after smaller meals. The medication works on brain appetite centres, potentially reducing food cravings and making calorie restriction more sustainable throughout the dose escalation journey. Unlike Mounjaro's dual GIP/GLP-1 approach, Wegovy targets GLP-1 receptors exclusively, providing focused appetite regulation that intensifies with each dose increase. Each injection delivers sustained semaglutide release over 7 days, maintaining consistent appetite suppression between weekly doses. This mechanism requires the structured dose comparison approach to build tolerance whilst maximising therapeutic benefits at the 2.4mg maintenance strength.
Ordering Authentic Wegovy: From Assessment To Delivery
EverydayMeds streamlines access to genuine Novo Nordisk Wegovy through our 3-minute online clinical assessment covering medical history, current medications, and weight management goals relevant to dose planning. GPhC-registered prescribers review applications within 3 working days (24 hours with express service), determining appropriate starting doses and escalation suitability based on individual circumstances. Once approved, we dispatch authentic Wegovy via next-day cold-chain delivery, maintaining 2-8°C temperature control throughout transit to preserve medication integrity. Each delivery includes dose escalation guidance, storage instructions, and batch verification details for authentic Novo Nordisk products. Our pharmacy team remains available for ongoing support throughout your dose progression, ensuring optimal treatment outcomes with genuine medication. This comprehensive service eliminates counterfeit risks whilst providing professional oversight for safe, effective weight management treatment.
Storage Advantages: Wegovy Vs Mounjaro Practical Comparison
Wegovy demonstrates superior storage flexibility in dose comparisons, maintaining stability for 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This advantage proves valuable for travel, work schedules, or temporary storage situations during your escalation journey from 0.25mg through to 2.4mg maintenance dosing. Both medications require initial refrigerator storage at 2-8°C, but Wegovy's extended room temperature tolerance offers practical benefits for consistent dosing adherence. The FlexTouch pen design provides reliable dose delivery across all escalation stages, with clear dose windows for verification. Authentic Novo Nordisk Wegovy pens feature distinctive clicks and resistance patterns that counterfeit versions cannot replicate, providing tactile confirmation of genuine medication during injection. Proper storage maintains semaglutide potency throughout the 20-week escalation protocol, ensuring each dose delivers intended therapeutic effects.
Verifying Authentic Wegovy In Your Dose Comparison Journey
Authentic Novo Nordisk Wegovy features specific verification markers that distinguish genuine medication from dangerous counterfeits circulating in UK markets. Each pen displays clear batch numbers, expiry dates, and Novo Nordisk branding with FlexTouch labelling that aligns with MHRA-approved packaging standards. The authentic dose window shows precise measurement markings, whilst genuine pens produce distinctive clicking sounds during dose selection that counterfeit versions typically cannot replicate. EverydayMeds provides batch verification documentation with every delivery, allowing cross-reference with Novo Nordisk's official authentication systems.
MHRA warnings about fake semaglutide products emphasise the importance of sourcing from GPhC-registered pharmacies like EverydayMeds (#9012878) rather than unregulated online suppliers. Counterfeit Wegovy may contain incorrect doses, expired ingredients, or harmful substitutes that compromise both safety and efficacy during your escalation protocol. Our genuine supply chain ensures each dose contains precisely the stated semaglutide concentration, from initial 0.25mg through maintenance 2.4mg, supporting reliable treatment outcomes throughout your weight management journey.
Complete Wegovy And Mounjaro Dose Comparison: Making Your Choice
Both Wegovy and Mounjaro offer structured dose escalation for weight management, but differ in mechanisms, timing, and storage requirements that influence treatment suitability. Wegovy's 5-stage protocol provides gradual semaglutide introduction over 20 weeks, whilst Mounjaro's tirzepatide targets dual GIP/GLP-1 pathways with different escalation timing. Storage comparison favours Wegovy's 6-week room temperature stability versus Mounjaro's 21-day limit, offering practical advantages for varied lifestyles. Pricing structures differ across escalation stages, with both medications requiring prescription-only access through clinical assessment. Your prescriber can evaluate individual factors including tolerance, medical history, and lifestyle requirements to determine which dose escalation protocol best suits your weight management goals. Both Wegovy and Mounjaro are available from EverydayMeds with full clinical support throughout your treatment journey, ensuring optimal outcomes with genuine, MHRA-regulated medication from trusted pharmaceutical manufacturers.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
